Thesis/Theses examined by Eickelberg, Oliver

Gerckens, Michael Wolfgang (2023): Discovery of new cinnamic acid amides as novel antifibrotic drugs. Dissertation, LMU München: Faculty of Medicine

Binzenhöfer, Leonhard (2021): Prolyl-3-hydroxylase 1 in idiopathic pulmonary fibrosis. Dissertation, LMU München: Faculty of Medicine

Ehlebracht, Catharina (2018): Monitoring der Bleomycin-induzierten Lungenfibrose durch repetitive Lungenfunktionsmessung im Maus-Modell und die Rolle der Protein-Arginin Methylierung für die Fibroseentwicklung. Dissertation, LMU München: Faculty of Medicine

Fernandez, Isis E. (2018): Biomarker discovery and drug testing in Idiopathic Pulmonary Fibrosis. Dissertation, LMU München: Faculty of Medicine

Noskovičová, Nina (2018): The lung fibroblast surface proteins PDGFRα and CDCP1 as profibrotic mediators in pulmonary fibrosis. Dissertation, LMU München: Faculty of Medicine

Günter, Stefanie (2017): The effect of immunoageing on the susceptibility to cigarette smoke induced COPD. Dissertation, LMU München: Faculty of Medicine

Hager, Katrin (2016): Immune cell characterization in the lung after acute and chronic cigarette smoke exposure in a mouse model of COPD. Dissertation, LMU München: Faculty of Medicine

Sarker, Rim Sabrina Jahan (2015): Role of CARM1 in regulation of alveolar epithelial senescence and emphysema susceptibility. Dissertation, LMU München: Faculty of Medicine